Akanda Corp. (AKAN)

USD 1.16

(5.45%)

Revenue Summary of Akanda Corp.

  • Akanda Corp.'s latest annual revenue in 2023 was 2.16 Million USD , down -17.55% from previous year.
  • Akanda Corp.'s latest quarterly revenue in 2024 Q2 was 477 Thousand USD , down 0.0% from previous quarter.
  • Akanda Corp. reported a annual revenue of 2.61 Million USD in annual revenue 2022, up 6223.0% from previous year.
  • Akanda Corp. reported a annual revenue of 41.43 Thousand USD in annual revenue 2021, up 1909.26% from previous year.
  • Akanda Corp. reported a quarterly revenue of 1.39 Million USD for 2023 Q2, up 100.0% from previous quarter.
  • Akanda Corp. reported a quarterly revenue of 381.3 Thousand USD for 2023 Q3, down -72.71% from previous quarter.

Annual Revenue Chart of Akanda Corp. (2023 - 2019)

Historical Annual Revenue of Akanda Corp. (2023 - 2019)

Year Revenue Revenue Growth
2023 2.16 Million USD -17.55%
2022 2.61 Million USD 6223.0%
2021 41.43 Thousand USD 1909.26%
2020 2062.00 USD 0.0%
2019 - USD 0.0%

Peer Revenue Comparison of Akanda Corp.

Name Revenue Revenue Difference
Collegium Pharmaceutical, Inc. 566.76 Million USD 99.619%
Embecta Corp. 1.12 Billion USD 99.807%
ANI Pharmaceuticals, Inc. 486.81 Million USD 99.556%
Dynavax Technologies Corporation 232.28 Million USD 99.07%
Esperion Therapeutics, Inc. 116.33 Million USD 98.143%
Pacira BioSciences, Inc. 674.97 Million USD 99.68%
PainReform Ltd. - USD -Infinity%
Aquestive Therapeutics, Inc. 50.58 Million USD 95.73%
Sunshine Biopharma, Inc. 24.09 Million USD 91.034%
SCYNEXIS, Inc. 140.14 Million USD 98.459%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -12.007%
Cosmos Health Inc. 53.37 Million USD 95.953%
Journey Medical Corporation 79.18 Million USD 97.272%
Sunshine Biopharma, Inc. 24.09 Million USD 91.034%
Safety Shot Inc 202.67 Thousand USD -965.798%
Alpha Teknova, Inc. 36.68 Million USD 94.112%
Intra-Cellular Therapies, Inc. 464.37 Million USD 99.535%
Bright Green Corporation 401.49 Thousand USD -438.008%
Procaps Group, S.A. 409.92 Million USD 99.473%
Theratechnologies Inc. 81.76 Million USD 97.358%
Harrow Health, Inc. 130.19 Million USD 98.341%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD 83.038%
Biofrontera Inc. 34.07 Million USD 93.66%
DURECT Corporation 8.54 Million USD 74.73%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 99.644%
Cronos Group Inc. 88.84 Million USD 97.569%
OptiNose, Inc. 70.98 Million USD 96.957%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 99.512%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD 66.836%
Organogenesis Holdings Inc. 433.14 Million USD 99.501%
Guardion Health Sciences, Inc. 12.24 Million USD 82.365%
Cumberland Pharmaceuticals Inc. 39.55 Million USD 94.539%
Radius Health, Inc. 2.88 Billion USD 99.925%
Universe Pharmaceuticals INC 32.3 Million USD 93.314%
ProPhase Labs, Inc. 44.38 Million USD 95.133%
Phibro Animal Health Corporation 1.01 Billion USD 99.788%
Procaps Group S.A. 409.92 Million USD 99.473%
Alvotech 91.43 Million USD 97.638%
TherapeuticsMD, Inc. 1.3 Million USD -65.903%
Viatris Inc. 15.42 Billion USD 99.986%
Rockwell Medical, Inc. 83.61 Million USD 97.417%
Aytu BioPharma, Inc. 81 Million USD 97.333%
SIGA Technologies, Inc. 139.91 Million USD 98.456%
Tilray Brands, Inc. 788.94 Million USD 99.726%
Lifecore Biomedical, Inc. 128.26 Million USD 98.316%
Shineco, Inc. 9.8 Million USD 77.963%
PetIQ, Inc. 1.1 Billion USD 99.804%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 12 Thousand USD -17900.433%
Neurocrine Biosciences, Inc. 1.88 Billion USD 99.886%
Alimera Sciences, Inc. 80.75 Million USD 97.325%
Silver Spike Investment Corp. 11.72 Million USD 81.573%
Assertio Holdings, Inc. 152.06 Million USD 98.58%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Petros Pharmaceuticals, Inc. 5.82 Million USD 62.901%
Clever Leaves Holdings Inc. 17.41 Million USD 87.598%
Cyclo Therapeutics, Inc. 1.07 Million USD -100.673%
Avadel Pharmaceuticals plc 27.96 Million USD 92.275%
Hempacco Co., Inc. 4.04 Million USD 46.608%
Talphera, Inc. 651 Thousand USD -231.805%
Alvotech 91.43 Million USD 97.638%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 99.318%
Lantheus Holdings, Inc. 1.29 Billion USD 99.833%
Currenc Group, Inc. 53.25 Million USD 95.944%
Kamada Ltd. 144.75 Million USD 98.508%
Indivior PLC 1.09 Billion USD 99.802%
Evoke Pharma, Inc. 5.18 Million USD 58.305%
Flora Growth Corp. 76.07 Million USD 97.16%
Cyclo Therapeutics, Inc. 1.07 Million USD -100.673%
Evolus, Inc. 202.08 Million USD 98.931%
HUTCHMED (China) Limited 837.99 Million USD 99.742%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 99.665%